Cormica Group, (previously known as WMP Group) provides testing services to the medical devices industry. Its clients range from blue chip/top 10 device manufacturers to smaller innovators with teams of 100 or less. We are partnering with CEO, Mark Hammond, to build a global platform providing unparalleled service levels in terms of technical quality, turnaround times and client service. The first cornerstones of the Group are Wickham Micro and MET, leaders in the UK in microbiology and physical testing respectively. Wickham, with its 60 years of heritage is the longest established micro lab in the UK, and MET has built its leading position in physical testing over the past 25 years. Between them their clients recognise their industry-leading technical expertise, along with high service levels and support on crucial applications to respective regulators.

Limerston initially engaged with Wickham, the first investment in the platform, in 2018. Engagement with MET followed in 2019, and after an extensive search persuaded Mark Hammond, Group CEO, to join. In 2021 we structured a carve out of Wickham’s microbiology business to create the Group, followed by the acquisition of MET.

We aim to invest in additional leading facilities in Europe and the US, partnering with them to support their growth and integrate them into the Group, improving client experience by enabling them to launch products quickly, safely and to more jurisdictions.